Qiagen (1QGEN) Stock Forecast & Price Target

0 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

1QGEN Analyst Ratings

Moderate Buy

7 Buy

6 Hold

0 Sell

Based on 13 analysts giving stock ratings to

Qiagen

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

1QGEN Stock 12 Month Forecast

Average Price Target

€42.00

▲(11.87% Upside)

Based on 13 Wall Street analysts offering 12 month price targets for Qiagen in the last 3 months. The average price target is €42.00 with a high forecast of €49.09 and a low forecast of €35.70. The average price target represents a 11.87% change from the last price of €37.54.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"27":"€27","50":"€50","32.75":"€32.8","38.5":"€38.5","44.25":"€44.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":49.08772715,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€49.09</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":41.997549905499994,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€42.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":35.7001652,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€35.70</span>\n  </div></div>","useHTML":true}}],"tickPositions":[27,32.75,38.5,44.25,50],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,38.16,39.00059439615384,39.84118879230769,40.68178318846154,41.522377584615384,42.36297198076923,43.20356637692308,44.044160773076925,44.884755169230765,45.72534956538461,46.56594396153846,47.406538357692305,48.24713275384615,{"y":49.08772715,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,38.16,38.45519614657692,38.750392293153844,39.045588439730764,39.34078458630769,39.63598073288461,39.93117687946153,40.22637302603846,40.52156917261538,40.8167653191923,41.11196146576923,41.40715761234615,41.702353758923074,{"y":41.997549905499994,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,38.16,37.970781938461535,37.78156387692307,37.59234581538461,37.40312775384615,37.21390969230769,37.024691630769226,36.83547356923077,36.64625550769231,36.45703744615385,36.267819384615386,36.078601323076924,35.88938326153846,{"y":35.7001652,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":38.76,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":40.75,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":40.72,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.328,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":43.762,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":40.943,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34.565,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.727,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.526,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34.134,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.8,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":37.345,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.16,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€49.09

Average Price Target€42.00

Lowest Price Target€35.70

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Lu Li

Bank of America Securities

€43.73→€44.63

Buy

18.87%

Upside

Reiterated

10/09/26

Qiagen price target raised to $50 from $49 at BofAQiagen price target raised to $50 from $49 at BofA

Luke Sergott

Barclays

€35.7→€49.09

Buy

30.76%

Upside

Upgraded

10/06/26

Qiagen upgraded to Overweight from Equal Weight at BarclaysQiagen upgraded to Overweight from Equal Weight at Barclays

Jan Koch

Deutsche Bank

€41.95

Buy

11.74%

Upside

Reiterated

09/24/26

Qiagen (QGEN) Receives a Buy from Deutsche Bank

Aisyah Noor

Morgan Stanley

€40→€42

Buy

11.88%

Upside

Reiterated

09/11/26

Qiagen price target raised to EUR 42 from EUR 40 at Morgan StanleyQiagen price target raised to EUR 42 from EUR 40 at Morgan Stanley

Harry Gillis

Berenberg Bank

€40.61

Hold

8.18%

Upside

Reiterated

09/10/26

Analysts Offer Insights on Healthcare Companies: Qiagen (NYSE: QGEN) and Monopar Therapeutics Inc (NASDAQ: MNPR)

Unknown Analyst

UBS

Not Ranked

UBS

€46.41→€41.95

Hold

11.74%

Upside

Initiated

09/08/26

Qiagen initiated with a Neutral at UBSQiagen initiated with a Neutral at UBS

Matt Larew

William Blair

―

Hold

―

Assigned

08/24/26

Qiagen: CEO Appointment and Strategic Review Temper Takeover Hopes, Justifying Hold Rating on Valuation

Unknown Analyst

DZ BANK AG

Not Ranked

DZ BANK AG

―

Buy

―

Reiterated

08/12/26

DZ BANK AG Reaffirms Their Buy Rating on Qiagen (QGEN)

Daniel Arias

Stifel Nicolaus

€35.7

Hold

-4.90%

Downside

Reiterated

08/11/26

Stifel Nicolaus Sticks to Their Hold Rating for Qiagen (QGEN)

Casey Woodring

J.P. Morgan

€44.63

Buy

18.87%

Upside

Reiterated

08/10/26

Analysts' Top Healthcare Picks: Qiagen (QGEN), Establishment Labs Holdings (ESTA)

‏Brendan Digan‏

Citi

€33.92→€40.16

Hold

6.99%

Upside

Reiterated

08/10/26

Qiagen price target raised to $45 from $38 at CitiQiagen price target raised to $45 from $38 at Citi

Tycho Peterson

Jefferies

―

Buy

―

Reiterated

08/06/26

Analysts Offer Insights on Healthcare Companies: Agilon Health (NYSE: AGL), Qiagen (NYSE: QGEN) and Coherus Biosciences (NASDAQ: CHRS)

Daniel Brennan

TD Cowen

€35.7→€39.27

Hold

4.61%

Upside

Reiterated

07/15/26

Qiagen price target raised to $44 from $40 at TD CowenQiagen price target raised to $44 from $40 at TD Cowen

Unknown Analyst

Kepler Capital

Not Ranked

Kepler Capital

€34.45

Hold

-8.23%

Downside

Initiated

06/25/26

Qiagen (QGEN) Gets a Hold from Kepler Capital

Catherine Ramsey Schulte

Robert W. Baird

€47.3→€38.38

Buy

2.23%

Upside

Upgraded

04/29/26

Qiagen upgraded to Outperform from Neutral at BairdQiagen upgraded to Outperform from Neutral at Baird

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Lu Li

Bank of America Securities

€43.73→€44.63

Buy

18.87%

Upside

Reiterated

10/09/26

Qiagen price target raised to $50 from $49 at BofAQiagen price target raised to $50 from $49 at BofA

Luke Sergott

Barclays

€35.7→€49.09

Buy

30.76%

Upside

Upgraded

10/06/26

Qiagen upgraded to Overweight from Equal Weight at BarclaysQiagen upgraded to Overweight from Equal Weight at Barclays

Jan Koch

Deutsche Bank

€41.95

Buy

11.74%

Upside

Reiterated

09/24/26

Qiagen (QGEN) Receives a Buy from Deutsche Bank

Aisyah Noor

Morgan Stanley

€40→€42

Buy

11.88%

Upside

Reiterated

09/11/26

Qiagen price target raised to EUR 42 from EUR 40 at Morgan StanleyQiagen price target raised to EUR 42 from EUR 40 at Morgan Stanley

Harry Gillis

Berenberg Bank

€40.61

Hold

8.18%

Upside

Reiterated

09/10/26

Analysts Offer Insights on Healthcare Companies: Qiagen (NYSE: QGEN) and Monopar Therapeutics Inc (NASDAQ: MNPR)

Unknown Analyst

UBS

Not Ranked

UBS

€46.41→€41.95

Hold

11.74%

Upside

Initiated

09/08/26

Qiagen initiated with a Neutral at UBSQiagen initiated with a Neutral at UBS

Matt Larew

William Blair

―

Hold

―

Assigned

08/24/26

Qiagen: CEO Appointment and Strategic Review Temper Takeover Hopes, Justifying Hold Rating on Valuation

Unknown Analyst

DZ BANK AG

Not Ranked

DZ BANK AG

―

Buy

―

Reiterated

08/12/26

DZ BANK AG Reaffirms Their Buy Rating on Qiagen (QGEN)

Daniel Arias

Stifel Nicolaus

€35.7

Hold

-4.90%

Downside

Reiterated

08/11/26

Stifel Nicolaus Sticks to Their Hold Rating for Qiagen (QGEN)

Casey Woodring

J.P. Morgan

€44.63

Buy

18.87%

Upside

Reiterated

08/10/26

Analysts' Top Healthcare Picks: Qiagen (QGEN), Establishment Labs Holdings (ESTA)

‏Brendan Digan‏

Citi

€33.92→€40.16

Hold

6.99%

Upside

Reiterated

08/10/26

Qiagen price target raised to $45 from $38 at CitiQiagen price target raised to $45 from $38 at Citi

Tycho Peterson

Jefferies

―

Buy

―

Reiterated

08/06/26

Analysts Offer Insights on Healthcare Companies: Agilon Health (NYSE: AGL), Qiagen (NYSE: QGEN) and Coherus Biosciences (NASDAQ: CHRS)

Daniel Brennan

TD Cowen

€35.7→€39.27

Hold

4.61%

Upside

Reiterated

07/15/26

Qiagen price target raised to $44 from $40 at TD CowenQiagen price target raised to $44 from $40 at TD Cowen

Unknown Analyst

Kepler Capital

Not Ranked

Kepler Capital

€34.45

Hold

-8.23%

Downside

Initiated

06/25/26

Qiagen (QGEN) Gets a Hold from Kepler Capital

Catherine Ramsey Schulte

Robert W. Baird

€47.3→€38.38

Buy

2.23%

Upside

Upgraded

04/29/26

Qiagen upgraded to Outperform from Neutral at BairdQiagen upgraded to Outperform from Neutral at Baird

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

MDWDMediwound

OVIDOvid Therapeutics

IMUXImmunic

ASNDAscendis Pharma

AORTArtivion

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Qiagen

3 Months

Jan KochDeutsche Bank

Success Rate

8/11 ratings generated profit

Average Return

+9.31%

Copying Jan Koch's trades and holding each position for 3 Months would result in 72.73% of your transactions generating a profit, with an average return of +9.31% per trade.

1 Year

Jan KochDeutsche Bank

Success Rate

11/11 ratings generated profit

Average Return

+19.11%

Copying Jan Koch's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +19.11% per trade.

2 Years

Jan KochDeutsche Bank

Success Rate

11/11 ratings generated profit

Average Return

+19.11%

Copying Jan Koch's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +19.11% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1QGEN Analyst Recommendation Trends

Rating

Jun 26

Jul 26

Aug 26

Sep 26

Oct 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 1QGEN has received 10 Buy Ratings, 9 Hold Ratings, and 0 Sell Ratings. 1QGEN average Analyst price target in the past 3 months is 42.00.

Each month's total comprises the sum of three months' worth of ratings.

1QGEN Financial Forecast

1QGEN Earnings Forecast

Next quarter’s earnings estimate for 1QGEN is €0.56 with a range of €0.55 to €0.58. The previous quarter’s EPS was €0.56. 1QGEN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 1QGEN has Performed in-line its overall industry.

1QGEN Sales Forecast

Next quarter’s sales forecast for 1QGEN is €479.54M with a range of €475.41M to €481.97M. The previous quarter’s sales results were €479.02M. 1QGEN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 1QGEN has Performed in-line its overall industry.

1QGEN Stock Forecast FAQ

What is IT:1QGEN’s average 12-month price target, according to analysts?

Based on analyst ratings, Qiagen NV’s 12-month average price target is 42.00.

What is IT:1QGEN’s upside potential, based on the analysts’ average price target?

Qiagen NV has 11.87% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Qiagen NV a Buy, Sell or Hold?

Qiagen NV has a consensus rating of Moderate Buy, which is based on 7 buy ratings, 6 hold ratings and 0 sell ratings.

What is Qiagen NV’s share price target?

The average share price target for Qiagen NV is 42.00. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €49.09 ,and the lowest forecast is €35.70. The average share price target represents 11.87% Increase from the current price of €37.54.

What do analysts say about Qiagen NV?

Qiagen NV’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.

How can I buy shares of Qiagen NV?

To buy shares of IT:1QGEN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Qiagen (1QGEN) Stock Forecast & Price Target

1QGEN Analyst Ratings

1QGEN Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Qiagen

1QGEN Analyst Recommendation Trends

1QGEN Financial Forecast

1QGEN Earnings Forecast

1QGEN Sales Forecast

1QGEN Stock Forecast FAQ

Detailed List of Analyst Forecasts